Yuichi Iwaki

Vermögen: 1 Mio $ am 30.04.2024

74 Jahre

Consumer Services

Health Technology

Non-Energy Minerals

Aktive Positionen von Yuichi Iwaki

Unternehmen	Position	Beginn	Ende
MEDICINOVA, INC.	Direktor/Vorstandsmitglied	01.03.2007	-
	Vorstandsvorsitzender	01.08.2005	-
	Gründer	26.09.2000	-
	Präsident	01.03.2006	-
	Vorsitzender	26.09.2000	01.03.2007
	Finanzdirektor/CFO	22.04.2020	19.06.2020
Avigen, Inc. Avigen, Inc. Medical SpecialtiesHealth Technology Avigen, Inc. produces and sells drugs, animal health products, and chemicals. The firm also develops and commercializes small molecules of therapeutics and biologics for use in the treatment of serious neurological and neuromuscular disorders. The company was founded in 1992 and is headquartered in La Jolla, CA.	Vorstandsvorsitzender	18.12.2009	-
	Direktor/Vorstandsmitglied	01.11.1994	18.12.2009
University of South Carolina School of Medicine	Corporate Officer/Principal	01.01.1992	-
University of Southern California University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA.	Corporate Officer/Principal	-	-

Unternehmen	Position	Beginn	Ende
University of Pittsburgh School of Medicine	Corporate Officer/Principal	01.01.1989	01.01.1991
Antyra, Inc. Antyra, Inc. Pharmaceuticals: MajorHealth Technology Antyra, Inc. develops cancer therapeutics. Its products include lead programs, a program to generate and develop disease-specific therapeutics; oncology leads, such as IGF-1R Antagonist, which represent a clinical strategy for the treatment of pancreatic and other cancers; and ANT-G12, a technology that isolates cytotoxic peptimetics that bind to cell surface targets expressed in a disease-specific context. The company was founded by by John K. A. Prendergast and Arthur J. Blume in 1996 and is headquartered in Edison, NJ.	Direktor/Vorstandsmitglied	-	-
AMCOL INTERNATIONAL CORPORATION	Vorsitzender	-	-
AMCOL INTERNATIONAL CORPORATION	Präsident	-	-

Sapporo Medical University School of Medicine

Doctorate Degree

International

Vereinigte Staaten	8
Japan	2

Operativ

Director/Board Member	3
Corporate Officer/Principal	3
Chief Executive Officer	2

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
MEDICINOVA, INC.	Health Technology

Private Unternehmen	3
Avigen, Inc. Avigen, Inc. Medical SpecialtiesHealth Technology Avigen, Inc. produces and sells drugs, animal health products, and chemicals. The firm also develops and commercializes small molecules of therapeutics and biologics for use in the treatment of serious neurological and neuromuscular disorders. The company was founded in 1992 and is headquartered in La Jolla, CA.	Health Technology
AMCOL International Corp. AMCOL International Corp. Construction MaterialsNon-Energy Minerals AMCOL International Corp. produces value-added, specialty minerals, and related product. The company was founded on December 30, 1959 and is headquartered in Hoffman Estates, IL.	Non-Energy Minerals
Antyra, Inc. Antyra, Inc. Pharmaceuticals: MajorHealth Technology Antyra, Inc. develops cancer therapeutics. Its products include lead programs, a program to generate and develop disease-specific therapeutics; oncology leads, such as IGF-1R Antagonist, which represent a clinical strategy for the treatment of pancreatic and other cancers; and ANT-G12, a technology that isolates cytotoxic peptimetics that bind to cell surface targets expressed in a disease-specific context. The company was founded by by John K. A. Prendergast and Arthur J. Blume in 1996 and is headquartered in Edison, NJ.	Health Technology